Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects

NCT ID: NCT02487680

Last Updated: 2017-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has previously been shown in healthy overweight subjects, that table water including a defined amount of amino acids and chromium can decrease the postprandial glucose. In this study, the effect of this table water on glucose excursions after a test meal containing a defined amount of available carbohydrates, protein and fat will be studied in healthy subjects. The study will be conducted in a cross -over design, double blinded and placebo controlled including 20 participants. The primary endpoint of the study is the incremental area under the curve for plasma glucose (iAUCgluc) within 180 minutes after ingestion of the meal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breakfast meal

A breakfast like meal will be provided together with a drink to overnight fasted subjects

Group Type EXPERIMENTAL

Amino Acids and chromium-picolinate containing drink

Intervention Type DIETARY_SUPPLEMENT

Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma

Placebo drink

Intervention Type DIETARY_SUPPLEMENT

Evaluation of the placebo supplement drink containing only aroma

Lunch meal

A lunch like meal will be provided together with a drink to overnight fasted subjects

Group Type EXPERIMENTAL

Amino Acids and chromium-picolinate containing drink

Intervention Type DIETARY_SUPPLEMENT

Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma

Placebo drink

Intervention Type DIETARY_SUPPLEMENT

Evaluation of the placebo supplement drink containing only aroma

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amino Acids and chromium-picolinate containing drink

Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma

Intervention Type DIETARY_SUPPLEMENT

Placebo drink

Evaluation of the placebo supplement drink containing only aroma

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stable body weight (no changes above 3 kg during the last 2 months)
* Good general health
* Body mass index 19 - 30 kg/m2 (normal to overweight)
* Fasting blood glucose below 6.1 mmol/L

Exclusion Criteria

* Any medication that could influence the study. Such as medication against diabetes, hypoglycemia, hypertension or hypercholesterolemia
* Psychiatric Disease
* Alcohol or drug abuse
* Smokers or people consuming snus
* Acute infections
* Vegetarians/vegans
* Suffering from Lactose or Gluten intolerance
* Pregnancy or Lactation
* Participation in another study at the same time
* Any other parameter that the PI will judge as inadequate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lund University

OTHER

Sponsor Role collaborator

DoubleGood AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Per Humpert, MD, Prof

Role: PRINCIPAL_INVESTIGATOR

Stoffwechselzentrum Rhein Pfalts, Mannheim, Germany and Department of internal medicine, University of Heidelberg, Germany

Ana Rascón, PhD, Prof

Role: STUDY_DIRECTOR

Food for Health Science Center, Lund University, Sweden

Kristina Andersson, PhD

Role: STUDY_CHAIR

Experimental Medical Science, Lund University, Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DoubleGood Lund

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chromium and Insulin Action
NCT00283777 COMPLETED PHASE4
Role of BCAA in Glucose Homeostasis
NCT05836350 NOT_YET_RECRUITING PHASE4
Chromium and Insulin Resistance
NCT00846248 COMPLETED NA